We are live on
!
Find out more
LCOV
London Company of Virginia Portfolio holdings
AUM
$16.2B
1-Year Est. Return
17.5%
This Fund
S&P 500
This Quarter
Est. Return
+1.83%
1 Year Est. Return
+17.5%
3 Year Est. Return
+53.53%
5 Year Est. Return
+68.8%
10 Year Est. Return
+271.54%
AUM
$8.89B
AUM Growth
+$111M
(+1.3%)
Cap. Flow
+$52.4M
Cap. Flow
% of AUM
0.59%
Top 10 Holdings %
Top 10 Hldgs %
32.71%
Holding
114
New
19
Increased
46
Reduced
38
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
The Mosaic Company
MOS
|
+$65.6M |
| 2 |
Eli Lilly
LLY
|
+$47.6M |
| 3 |
KMR
KINDER MORGAN MANAGEMENT LLC
KMR
|
+$28.2M |
| 4 |
Pultegroup
PHM
|
+$9.19M |
| 5 |
MBIA
MBI
|
+$7.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MWV
MEADWESTVACO CORP
MWV
|
+$104M |
| 2 |
HTS
HATTERAS FINANCIAL CORP
HTS
|
+$21.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$15.2M |
| 4 |
Tredegar Corp
TG
|
+$8.07M |
| 5 |
Nu Skin
NUS
|
+$7.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 15.34% |
| 2 | Consumer Discretionary | 14.5% |
| 3 | Industrials | 13% |
| 4 | Financials | 10.84% |
| 5 | Consumer Staples | 10.49% |
Similar funds
UCFA
IG
EIP
CI
MG
CLGM
LCIP
London Company of Virginia's Q1 2014 Portfolio in Review
As of Q1 2014, London Company of Virginia held 114 positions worth $8.89B, up 1.3% from $8.78B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
London Company of Virginia's Q1 2014 filing shows 19 new, 46 increased, 38 reduced and 6 closed positions. Its largest new stake was The Mosaic Company: 1,377,677 shares worth $68.9M. The largest sale was MEADWESTVACO CORP, an estimated $104M.
By sector, the portfolio is most concentrated in Materials at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Industrials.
- London Company of Virginia's largest Q1 2014 buy was The Mosaic Company: 1,377,677 shares worth $68.9M.
- London Company of Virginia added most to Eli Lilly in Q1 2014, an estimated $47.6M increase.
- London Company of Virginia's biggest Q1 2014 reduction was Bristol-Myers Squibb, cutting an estimated $15.2M.
- London Company of Virginia fully exited MEADWESTVACO CORP in Q1 2014, selling an estimated $104M.
- London Company of Virginia's ten largest holdings make up 33% of its $8.89B portfolio in Q1 2014.
- London Company of Virginia opened 19 new positions and closed 6 in Q1 2014.
- London Company of Virginia's portfolio value rose 1.3% quarter-over-quarter to $8.89B.
Based on London Company of Virginia's 13F filing for Q1 2014, filed 8 May 2014.